2013 論文・総説（英語） Publications（International）
| 1 |
Kono Y, Horii T, Nishiyama A. J Hypertens. 2013 Jan;31(1):42-43. |
 |
| 2 | (Pro)renin receptor and insulin resistance: possible roles of angiotensin II- dependent and -independent pathways. Rafiq K, Mori H, Masaki T, Nishiyama A. Mol Cell Endocrinol. 2013. 378:41-45. |
|
| 3 |
Shibayama Y, Hitomi H, Nakano D, Kobori H, Mori H, Deguchi K, Masaki T, Ichihara A, Nishiyama A. Front Biosci. 2013 Jan 1;5:697-705. |
|
| 4 | Angiotensin II receptor blockade reduces salt sensitivity of blood pressure through restoration of renal nitric oxide synthesis in patients with diabetic nephropathy. Imanishi M, Okada N, Konishi Y, Morikawa T, Maeda I, Kitabayashi C, Masada M, Shirahashi N, Wilcox CS, Nishiyama A. J Renin-Angiotensin-Aldosterone Syst. 2013 Mar;14(1):67-73. |
|
| 5 |
Fan YY, Kobori H, Nakano D, Hitomi H, Mori H, Masaki T, Sun YX, Zhang L, Huang W, Zhu B, Li P, Nishiyama A. Horm Metab Res. 2013, May;45(5):338-343. |
|
| 6 | Effects of angiotensin II AT1 receptor blockade on high fat diet-induced
vascular oxidative stress and endothelial dysfunction in Dahl salt-sensitive
rats. Kosaka S, Pelish N, Rahman M, Nakano D, Hitomi H, Kobori H, Fukuoka N, Kobara H, Mori H, Masaki T, Cervenka L, Matsumura Y, Houchi H, Nishiyama A. J Pharm Sci. 2013 Feb 19;121(2):95-102. |
|
| 7 |
Kobori H, Mori H, Masaki T, Nishiyama A. Curr Pharm Design. 2013;19(17):3033-3042. |
|
| 8 |
Sofue T, Inui M, Kiyomoto H, Moriwaki K, Hara T, Yamaguchi K, Fukuoka N, Banno K, Nishiyama A, Kakehi Y, Kohno M. Clin Exp Nephrol. 2013 Oct;17(5):743-749. |
|
| 9 |
Honetschlagerov Z, Kitada K, Huskov Z, Sporkov A, Kopkan L, Burgelov M, Varcabov S, Nishiyama A, Hwang SH, Hammock BD, Imig JD, Kramer HJ, Kujal P, Vernerov Z, Cervenka L. J Hypertens. 2013 Feb;31(2):321-332. |
|
| 10 |
Vazquez-Medina JP, Sonanez-Organis JG, Rodriguez R, Viscarra JA, Nishiyama A, Crocker DE, Ortiz RM. J Exp Biol. 2013, 216:2870-2878. |
|
| 11 | Effects of angiotensin-converting enzyme inhibitors and angiotensin II
receptor blockers on accumulation of aliskiren in the kidney. Rahman A, Ohmori K, Kohno M, Nishiyama A. J Hypertens. 2013 Apr;31(4):659-660. |
|
| 12 |
Ohnishi K, Murase M, Nakano D, Pelisch N, Hitomi H, Kobori H, Morimoto S, Mori H, Masaki T, Ohmori K, Kohno M, Ichihara A, Nishiyama A. J Pharm Sci. 2013 Jun 20;122(2):103-108. |
|
| 13 | Latent IgA deposition from donor kidneys does not affect transplant prognosis,
irrespective of mesangial expansion. Sofue T, Inui M, Hara T, Moritoki M, Nishioka S, Nishijima Y, Moriwaki K, Hayashida Y, Ueda N, Kushida Y, Haba R, Nishiyama A, Kakehi Y, Kohno M. Clin Transplant. 2013 Nov-Dec;27 Suppl 26:14-21. |
|
| 14 | Roles of Na+/H+ exchanger type 1 and intracellular pH in angiotensin II-induced
reactive oxygen species generation and podocyte apoptosis. Liu Y, Hitomi H, Diah S, Deguchi K, Mori H, Masaki T, Nakano D, Kobori H, Nishiyama A. J Pharm Sci. 2013;122(3):176-183. |
|
| 15 | RAS inhibition attenuates cognitive impairment by reducing blood-brain
barrier permeability in hypertensive subjects.? Pelisch N, Hosomi N, Mori H, Masaki T, Nishiyama A. Curr Hypertens Rev. 2013, 2013 May;9(2):93-98. |
|
| 16 | Angiotensin receptor mediated oxidative stress is associated with impaired cardiac redox signaling and mitochondrial function in insulin resistant rats. Vazquez-Medina JP, Popovich I, Thorwald MA, Viscarra JA, Rodriguez R, Sonanez-Organis JG, Lam L, Peti-Peterdi J, Nakano D, Nishiyama A, Ortiz RM. Am J Physiol Heart Circ Physiol. 2013;305(4):H599-607. |
|
| 17 | Amelioration of angiotensinII-induced salt-sensitive hypertension by L-FABP
in proximal tubules. Amelioration of angiotensinII-induced salt-sensitive hypertension by L-FABP in proximal tubules. Osaki K, Suzuki Y, Sugaya T, Tanifuji C, Nishiyama A, Horikoshi S, Tomino Y. 2013 Hypertension. 2013 Oct;62(4):712-718. |
|
| 18 | Complement 3 activates the renal renin-angiotensin system by induction
of epithelial-to-mesenchymal transition of the nephrotubulus in mice. Zhou X, Fukuda N, Matsuda H, Endo M, Wang X, Saito K, Ueno T, Matsumoto T, Matasumoto K, Soma M, Kobayashi N, Nishiyama A. Am J Physiol Renal Physiol. 2013 Oct 1;305(7):F957-967. |
|
| 19 | Do RAS inhibitors protect the brain from cerebral ischemic injury? Hosomi N, Nishiyama A, Matsumoto M. Curr Hypertens Rev. 2013 May;9(2):86-92. |
|
| 20 | Renin-Angiotensin system in neuronal disease. Mogi M, Hosomi N, Nishiyama A, Ohshima K. Curr Hypertens Rev. 2013 May;9(2):85. |
|
| 21 | Aldosterone aggravates glucose intolerance induced by high fructose. Sherajee SJ, Rafiq K, Nakano D, Mori H, Kobara H, Hitomi H, Fujisawa Y, Kobori H, Masaki T, Nishiyama A. Eur J Pharmacol 2013 Nov 15;720(1-3):63-68. |
|
| 22 | Calcium channel blocker enhances beneficial effects of an angiotensin II
AT1 receptor blocker against cerebrovascular-renal injury in type 2 diabetic
mice. Rafiq K, Sherajee SJ, Hitomi H, Nakano D, Kobori H, Ohmori K, Mori H, Kobara H, Masaki T, Kohno M, Nishiyama A. PLoS ONE. 2013 Dec 10;8(12):e82082. |
|
| 23 | Oxidative Stress/Angiotensinogen/Renin-Angiotensin System Axis in Patients
with Diabetic Nephropathy. Kamiyama M, Urushihara M, Morikawa T, Konishi Y, Imanishi M, Nishiyama A, Kobori H. Int J Mol Sci 2013 Nov 21;14(11):23045-23062. |
|
| 24 | Aldosterone: a mediator of retinal ganglion cell death and the potential
role in the pathogenesis in normal-tension glaucoma. Nitta E, Hirooka K, Tenkumo K, Fujita T, Nishiyama A, Nakamura T, Itano T, Shiraga F. Cell Death Dis. 2013 Jul 4;4:e711. |
|
| 25 | Novel algorithm for background
correction of the quantitative spectroscopic tomography of the biogenic-substances Pradeep K. W. Abeygunawardhana, Wei Qi, Daisuke Kojima, Satoru Suzuki, Akira Nishiyama, Ichirou Ishimaru Progress in Biomedical Optics and Imaging - Proceedings of SPIE 8591 2013 |
|
| 26 | Role of (pro)renin receptor in Ang II-mediated EGF receptor transactivation. Yuki Shibayama, Hirofumi Hitomi, Daisuke Nakano, Hiroyuki Kobori, Hirohito Mori, Kazushi Deguchi, Tsutomu Masaki, Atsuhiro Ichihara, Akira Nishiyama Frontiers in bioscience (Elite edition) 2013 Jan. 5 697 - 705 |
|
| 27 | Adipose Angiotensinogen is Upregulated during Insulin Resistance in OLETF Rats. David Nicolas Araiza, Jacqueline N. Minas, Ruben Rodriguez, Daisuke Nakano, Akira Nishiyama, Rudy M. Ortiz. FASEB JOURNAL2013 Apr. 27 |
|
| 28 | Angiotensin Receptor Blockade Reduces Oxidative Stress while Improving Redox Signaling and Mitochondrial Function in the Heart of Diet-induced Obese Insulin Resistant Rats. Jose Pablo Vazquez-Medina, Irina Popovich, Max A. Thorwald, Ruben Rodriguez, Jose A. Viscarra, Lisa Lam, Janos Peti-Peterd, Daisuke Nakano, Akira Nishiyama, Rudy M. Ortiz FASEB JOURNAL2013 Apr. 27 |
|
| 29 | Renal senescent cells accumulated in type 2 diabetic kidney can be removed by telmisartan but not by tempol. Daisuke Nakano, Kento Kitada, Hiroyuki Ohsaki, Hirofumi Hitomi, Hiroyuki Kobori, Masahito Imanishi, Akira Nishiyama JOURNAL OF PHARMACOLOGICAL SCIENCES2013 121 91P - 91P |
|
| 30 | Urinary angiotensinogen as a predictive marker of renoprotective effect of olmesartan in patients with metabolic syndrome. Hirofumi Hitomi, Hiroyuki Kobori, Fumihiro Tomoda, Satoshi Morimoto, Toshiki Fukui, Koichi Hasegawa, Tsukasa Nakamura, Daisuke Nakano, Masakazu Kohno, Akira Nishiyama JOURNAL OF PHARMACOLOGICAL SCIENCES 121 111P - 111P 2013 121 111P - 111P |
|
| 31 | Precision Controlled Variable Phase Filter for Imaging Type Two-Dimensional Spectroscopic Tomography. Pradeep Kumara Wijesekara Abeygunawardhana, Satoru Suzuki, Ichirou Ishimaru, Akira Nishiyama 2013 ASE/IEEE INTERNATIONAL CONFERENCE ON SOCIAL COMPUTING (SOCIALCOM) 2013 858 - 863 |
|
| 32 | Compact Optical System for Imaging type Two-dimensional Spectroscopic Tomography. Pradeep K. W. Abeygunawardhana, Shou Nakada, Satoru Suzuki, Akira Nishiyama, Ichirou Ishimaru 8TH IEEE INTERNATIONAL CONFERENCE ON INDUSTRIAL AND INFORMATION SYSTEMS (ICIIS) 2013 471 |
|